Here we report the first case of cholangiolocellular carcinoma (CoCC) visualized with contrast-enhanced ultrasonography (CEUS) using a second-generation contrast agent, Sonazoid TM . A 76-year-old man was admitted to our hospital for evaluation of a hepatic tumor. The tumor was described to have hyper-enhancement in the early phase and persistent enhancement in the late phase by contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI), as well as hypervascularity by angiography. CEUS assessment of the nodule showed diffuse and homogeneous enhancement in the pure arterial phase, which became progressively hypoechoic relative to the adjacent liver parenchyma during the portal vein and late phases (mixed vascular phase), and showed a contrast defect with unclear border in the Kupffer phase.
Introduction
Cholangiolocellular carcinoma (CoCC) was first reported as an adenocarcinoma originating from the ductules/canals of Hering.
1 Considered to be derived from hepatic stem cell carcinoma 2 , CoCC is categorized as a subtype of cholangiocellular carcinoma (CCC) based on criteria from the World Health
Organization. 3 In Japan, CoCC was recently classified as an independent primary liver cancer in 2008. 4 CoCC has been reported to account for approximately 1%
of primary liver cancers. 1 In a Japanese study, four cases of CoCC were found in 708 (0.56%) consecutively resected cases of primary liver cancer. 5 CoCC can be clinically misdiagnosed as hepatocellular carcinoma (HCC) because many patients are infected with hepatitis C or B virus. 6 Furthermore, the features of CoCC in ultrasonography have not been fully elucidated.
Contrast-enhanced ultrasonography (CEUS) is a useful tool for the diagnosis of hepatic tumors 7 , evaluation of malignancy grade and treatment response, and CEUS-guided percutaneous local ablation therapy. [7] [8] [9] Injection of Sonazoid TM (perfluorobutane) 10 , a second-generation contrast agent for ultrasonography, was approved in Japan for imaging lesions associated with hepatic cancer via ultrasound in 2007. However, due to the rarity of CoCC, few studies combining the 
Discussion
The clinical and imaging features of CoCC have not been fully characterized because only a small number of cases have been previously reported. 5, 6, [11] [12] [13] Most CoCC cases have hyper-enhancement in the early phase of contrast enhanced CT or MRI and hypervascularity in angiography. 6 , 13 Persistent This was also the case in our patient; a contrast defect was seen in the Kupffer phase during CEUS.
In a report of overt HCC visualized using Sonazoid TM , a pure arterial supply was seen in the pure arterial phase, hypervascularity in the mixed vascular phase, and a contrast defect in the Kupffer phase. 17 Similar characteristics in the arterial
Page 10 of 21
The Japan Society of Hepatology, Tokyo, Japan Hepatology Research phase of this case were observed in that we recognized the tumor with strongly homogeneous hyperperfusion which was induced by blood pooling; assessment of microvessel density using immonohistochemical staining of the biopsy specimen for specific endothelial cell markers, such as CD 34, 19 showed an abundance of capillary endothelial vessels in the tumor. (Figure 4e ) On the other hand, one report on common HCC using Sonazoid TM showed fast washout in the late vascular phase three minutes after injection of Sonazoid TM . 18 Visualization of CCC using Sonazoid TM has not yet been reported in English literature. However, it has been reported using other second-generation contrast agents, and perfusion images of almost all cases revealed hyperperfusion in the arterial phase 20, 21 , followed by punched-out contrast defects and relatively rapid washout in subsequent portal and/or sinusoidal phases. 20 The characteristics of this case in the mixed vascular phase are comparable to those of common HCC and CCC in that washout relatively earlier in the mixed vascular phase was described. We cannot generalize that all cases of CoCC show hyperperfusion in the arterial phase, relatively rapid washout in the mixed phase, and complete contrast defect in the Kupffer phase because CoCC can show several pathologically different patterns. 22 Furthermore, more cases and comparisons with hepatocellular Superparamagnetic iron oxide magnetic resonance imaging showed that the rumor had no decrease in signal intensity in T2 weighted images. 
